![Oncopeptides, Audiocast with teleconference, Q2'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/c157e3ee-2c3d-4254-93cf-c802cf91837d.png)
Oncopeptides
2.49 SEK -0.4%1 investor is following this company
Oncopeptides is a biotech company that develops drugs for difficult-to-treat hematological diseases. The company uses its PDC platform to develop peptide-linked drugs that selectively deliver cytotoxic drugs into cancer cells. The company has drugs in commercialization and several drug candidates under development. Oncopeptide's head office is located in Stockholm.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
ONCO
Daily low / high price
2.47 / 2.55
SEK
Market cap
535.81M SEK
Turnover
1.15M SEK
Volume
458K
Latest videos
Financial calendar
Interim report
2024-08-14
Interim report
2024-11-07
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
HealthCap VIII L.P. | 12.7 % | 12.9 % |
Avanza Pension | 7.9 % | 8.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
![Oncopeptides, Audiocast with teleconference, Q2'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/c157e3ee-2c3d-4254-93cf-c802cf91837d.png)
Första patienten i Oncopeptides studie för inhämtande av real world-data för Pepaxti i Tyskland rekryterad
First patient enters Oncopeptides study aiming to gain real-world insights from Pepaxti in Germany
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Finansinspektionen: Flaggningsmeddelande i Oncopeptides AB
Finansinspektionen: Flaggningsmeddelande i Oncopeptides AB
Finansinspektionen: Flaggningsmeddelande i Oncopeptides AB
Antal aktier och röster i Oncopeptides
Number of shares and votes in Oncopeptides
Oncopeptides utser första läkemedelskandidaten från sin SPiKE-plattform
Oncopeptides selects first candidate drug from its SPiKE platform
Finansinspektionen: Flaggningsmeddelande i Oncopeptides AB
Finansinspektionen: Flaggningsmeddelande i Oncopeptides AB
Finansinspektionen: Flaggningsmeddelande i Oncopeptides AB
Finansinspektionen: Flaggningsmeddelande i Oncopeptides AB
Finansinspektionen: Flaggningsmeddelande i Oncopeptides AB
Kommuniké från årsstämma i Oncopeptides AB (publ)
Bulletin from the Annual General Meeting in Oncopeptides AB (publ)
Antal aktier och röster i Oncopeptides
Number of shares and votes in Oncopeptides
![Oncopeptides, Audiocast with teleconference, Q1'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/23d2417d-1e9d-42db-991d-bf5d3bdd2ec0.png)